Navigation Links
First Whole Genome Map of Genetic Variability in Parkinson’s Disease

In findings with implications for pandemic influenza, a new study reports for the first time that a less-virulent strain of avian influenza virus can spread from poultry to humans. The research appears in the October 1 issue of The Journal of Infectious Diseases, now available online.

Crossing the species barrier is an important step in the development of a flu virus with pandemic potential. Previous studies have focused on the ability of highly pathogenic strains, such as H5N1 "bird flu" circulating in Asia, to spread from poultry to humans. The new study shows less pathogenic strains are also capable of jumping to humans, giving them the opportunity to swap genetic material with human strains, which could result in a more virulent virus.

Researchers in Italy studied outbreaks that occurred among poultry between 1999 and 2003, to determine the risk of avian influenza virus transmission to persons in contact with the animals. The outbreaks occurred in northern Italy in regions where the majority of the country's commercial poultry are raised on farms. Most previous cases of human infection with avian influenza viruses have involved close contact with infected poultry, particularly ill or dying chickens.

The investigators performed a serologic analysis of individuals exposed to infection during the outbreaks, collecting 983 blood samples from poultry farm workers in the outbreak regions. Blood was tested using three different techniques to ensure the validity of results.

The outbreaks involved two serotypes of avian influenza: one low and one highly pathogenic H7N1 and a low pathogenic H7N3 virus. Seven individuals exposed to the more recent outbreak of low pathogenic H7N3 tested seropositive for H7N3. The infected persons came from different farms in two locations and had close contact with turkeys or chickens. No serious symptoms were reported in connection with the infections.

The authors of the study, Dr. Isabella Donate lli of Istituto Superiore di Sanit?in Rome and colleagues, noted that their work provides the first serologic evidence of transmission of low pathogenic strains of avian influenza virus to humans during an outbreak in domestic poultry. Previous reports of human infection in Asia, Canada, and the Netherlands have been associated, in contrast, with highly pathogenic strains. The investigators emphasized that their study probably underestimates the real infection rate of the two strains among exposed individuals, since blood samples were considered positive only if they repeatedly produced unequivocal positive results using several different serologic techniques. They commented, however, that very sensitive serologic techniques such as those developed in the study provide an efficient tool for preventing or controlling the spread of avian flu to humans.

The authors say their findings highlight the importance of improving disease surveillance not only during outbreaks of highly pathogenic avian flu, but also when less pathogenic strains are circulating. To forestall genetic exchange between human and avian strains, as in mixed infections, they emphasized that poultry workers should be systematically vaccinated, pointing out that such workers are identified as high-risk and included in the annual Italian vaccination campaign.

In an accompanying editorial, Frederick Hayden, MD, of the University of Virginia and Alice Croisier, MD, of the World Health Organization concluded, "The transmissibility of avian viruses may increase as the viruses adapt to humans. In affected countries, public education about simple precautionary measures for food preparation, poultry handling, and avoidance of contaminated water are essential until specific prevention measures such as vaccines become available."


'"/>

Source:


Related biology news :

1. Timing is everything: First step in protein building revealed
2. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
3. First atlas of key brain genes could speed research on cancer, neurological diseases
4. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
5. NYCs First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention
6. First real-time view of developing neurons reveals surprises, say Stanford researchers
7. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
8. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
9. First frozen egg baby born in Canada
10. Human Cells Filmed Instantly Messaging for First Time
11. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
(Date:2/23/2017)... and NEW YORK , ... Lumeon , a leading digital health company, ... a provider of telemedicine and remote patient monitoring, ... for telemedicine reimbursements.  DN Telehealth ... patients, in real-time, extending consultations beyond a physical ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... SEATTLE , Feb. 23, 2017  Seattle,s upscale Capitol ... like a strange place for a head lice treatment salon ... nestled between a Tuscan restaurant and a French bistro on ... it,s perfect. "We aren,t just any old lice clinic, we ... to feel comfortable, and release some of the stigma associated ...
Breaking Biology Technology: